Focus: Octant Biotech is a public small-molecule biotech company headquartered in Emeryville, CA, focused on ophthalmology with 501-1000 employees.
Profile data last refreshed 7h ago · AI intelligence enriched 3w ago
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Octant offers stability through public status and therapeutic focus, but severely limited hiring and opacity around pipeline and financials warrant caution for growth-oriented candidates.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Octant Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Octant Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company